A joint research team from HKUMed and HKUST has demonstrated that ZCB11, a broadly neutralizing antibody derived from a local mRNA-vaccinee, shows pot...Read more

Researchers at the AIDS Institute, Department of Microbiology, and State Key Laboratory of Emerging Infectious Diseases at HKUMed, in collaboration wi...Read more

Background Vaccines in emergency use are efficacious against COVID-19, yet vaccine-induced prevention against nasal SARS-CoV-2 infection remains subo...Read more

© 2021 Elsevier Inc. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst in the upper respiratory portal for high...Read more

Researchers at the AIDS Institute, HKUMed, investigated the role of human immune responses in acute SARS-CoV-2 infection. The study found that acute S...Read more

The strikingly high transmissibility and antibody evasion of SARS-CoV-2 Omicron variants have posed great challenges to the efficacy of current vaccin...Read more

Researchers at HKUMed have conducted a study to identify an effective vaccine regimen to prevent SARS-CoV-2 nasal infection. The study found that a co...Read more

Increasing spread by SARS-CoV-2 Omicron variants challenges existing vaccines and broadly reactive neutralizing antibodies (bNAbs) against COVID-19. H...Read more

The airways and alveoli of the human respiratory tract are lined by two distinct types of epithelium, which are the primary targets of respiratory vir...Read more

The SARS-CoV-2 pandemic has resulted in millions of infections, yet the role of host immune responses in early COVID-19 pathogenesis remains unclear. ...Read more